Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus Among Patients With Systemic Lupus Erythematosus: A Population-Based Study.
Shahrzad SalmasiEric C SayreJuan Antonio Aviña-ZubietaJohn M EsdaileMary A De VeraPublished in: Arthritis care & research (2021)
Our findings of a protective effect of adherence to antimalarials in preventing type 2 DM provides further support for the importance of adherence to antimalarials to obtain the benefits of therapy.